美国持续阳压呼吸器(CPAP) 设备市场：市场规模、份额、趋势分析（按连接方式和最终用途）、细分市场预测（2025-2030 年）

美国持续正压呼吸器市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国持续性阳压呼吸器（CPAP）设备市场预计到2030年将达到8.2085亿美元，2025年至2030年期间的复合年增长率为4.44%。

市场受到多种因素的推动，例如睡眠呼吸中止症和呼吸系统疾病的盛行率不断上升、CPAP 设备技术的进步、对睡眠呼吸中止症的认识和诊断不断提高以及支持性报销政策。

技术进步是美国CPAP 市场的另一个关键驱动力。持续的技术创新使得设备更加易于使用、更安静、更紧凑，从而提高了患者的舒适度和依从性。远端监控和连接等创新技术的引入使患者能够追踪他们的睡眠模式和治疗进度，鼓励他们积极参与医疗保健。

由于医疗和政府机构加强了宣传宣传活动，越来越多的人寻求睡眠呼吸中止症的诊断和治疗。此外，保险公司优惠的报销政策使得更多人可以接受 CPAP 治疗。认识到 CPAP 疗法在预防未治疗的睡眠呼吸中止症相关併发症的长期益处，医疗保健提供者现在更有可能推荐和开立 CPAP 设备。

美国持续正压呼吸器市场：概述

• 根据连接方式，预计 2024 年网路共享将占据最大的市场占有率，达到 68.83%，并在预测期内以最快的复合年增长率成长。该领域的成长得益于睡眠呼吸中止症管理的进步，例如即时监测和改进的客製化治疗技术整合。
• 根据最终用途，居家医疗领域预计将在 2024 年占据最大的市场占有率，并在预测期内以最快的复合年增长率成长。阻塞型睡眠呼吸中止症(OSA) 的日益流行和 CPAP 技术的进步推动了这个细分市场的扩张，导致居家医疗CPAP 治疗越来越受到患者的欢迎，成为一种经济实惠、舒适且方便的解决方案。
• 美国CPAP 设备市场的主要企业包括 ResMed、Koninklijke Philips NV、Fisher &Paykel Healthcare Limited 和 Medical Depot, Inc.
• 2024年11月，Fisher & Paykel Healthcare在美国推出了F&P Nova Micro鼻枕面罩。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

• 市场联动展望
  • 母市场展望
  • 相关/附随市场展望
• 市场趋势与展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制分析
  • 市场机会分析
  • 市场问题分析
• 美国CPAP 设备市场：分析工具、PESTEL 分析
  • 政治/法律
  • 经济与社会
  • 科技
  • 环境
• 美国CPAP设备市场：波特五力分析
• COVID-19影响分析

第四章美国CPAP设备市场：按连接方式的估计和趋势分析

• 美国CPAP 设备市场：以连结方式进行销售分析
• 美国CPAP 设备市场（按仪錶板和连接方式）
• 按连接方式分類的市场趋势和市场占有率分析（2024 年和 2030 年）
• 按连线方式
• 可连接
  • 蓝牙连接CPAP
  • Wi-Fi/蜂窝 CPAP
  • 混合连接
• 未连接

第五章美国CPAP 设备市场：按最终用途进行的估算和趋势分析

• 美国CPAP 设备市场：以最终用途分類的销售分析
• 美国CPAP 设备市场（按仪表板和最终用途划分）
• 按最终用途分類的市场趋势和市场占有率分析（2024 年和 2030 年）
• 按最终用途
• 居家医疗
• 医院和诊所
• 其他（护理设施等）

第六章 竞争态势

• 公司分类
• 主要企业进入、退出策略及对竞争对手的影响
• 企业市场分析
• 公司份额分析（%，2012-2024）
• 公司简介/上市公司
  • ResMed
  • Koninklijke Philips NV
  • Fisher &Paykel Healthcare Limited
  • React Health（3B Medical）
  • Lowenstein Medical
  • BMC Medical
  • Wellell（Apex Medical）
  • Armstrong Medical
  • Breas Medical
  • SEFAM
  • Smiths Group PLC
  • Transcend Inc.（Somnetics International, Inc.）
  • Trudell Medical（Vyaire）
  • Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
  • Invacare Corporation
  • 其他的

U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends:

The U.S. continuous positive airway pressure devices market is anticipated to reach USD 820.85 million by 2030, registering a CAGR of 4.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.

Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.

Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.

U.S. Continuous Positive Airway Pressure Devices Market Report Highlights:

• On the basis of connectivity, the connected segment held the largest market share of 68.83% in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The growth of this segment is driven by advancements in sleep apnea management, including improved technology integration for real-time monitoring and tailored care, which enhances user adherence and treatment effectiveness.
• On the basis of end use, the home care settings segment held the largest market share in 2024 and is anticipated to grow at the fastest CAGR for the forecast period. The expansion of this segment is driven by the increasing prevalence of obstructive sleep apnea (OSA) and advancements in CPAP technology, which are increasing the adoption of homecare CPAP therapy as an affordable, comfortable, and convenient solution for patients.
• Some prominent players in the U.S. CPAP devices market include ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
• In November 2024, Fisher & Paykel Healthcare introduced the F&P Nova Micro nasal pillow mask in the U.S., marking the company's smallest and lightest CPAP therapy mask so far.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
  • 1.4.6. Research Assumption
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Data Visualization
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. Objectives
  • 1.8.1. Objective - 1
  • 1.8.2. Objective - 2
  • 1.8.3. Objective - 3
• 1.9. List of Secondary Sources
• 1.10. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. U.S. CPAP Devices Market
  • 2.1.1. Market Snapshot
  • 2.1.2. Segment Snapshot
    • 2.1.2.1. Connectivity segment outlook
    • 2.1.2.2. End Use segment outlook
  • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising incidence of obstructive sleep apnea (OSA)
    • 3.3.1.2. Technological advancements
    • 3.3.1.3. Supportive initiatives by government and private organizations for CPAP devices
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Product recalls & failure
    • 3.3.2.2. Complex regulatory framework pertaining to CPAP devices
  • 3.3.3. Market Opportunity Analysis
    • 3.3.3.1. Growing adoption of CPAP devices in home care settings
  • 3.3.4. Market Challenges Analysis
    • 3.3.4.1. Regulatory and reimbursement challenges
• 3.4. U.S. CPAP Devices Market Analysis Tools: PESTEL
  • 3.4.1. Political & Legal
  • 3.4.2. Economic & Social
  • 3.4.3. Technology
  • 3.4.4. Environment
• 3.5. U.S. CPAP Market Analysis Tools: Porter's
• 3.6. COVID 19 Impact Analysis

Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis

• 4.1. U.S. CPAP Devices Market: Connectivity Movement Analysis
• 4.2. U.S. CPAP Devices Market: Connectivity Segment Dashboard
• 4.3. Connectivity Movement & Market Share Analysis, 2024 & 2030
• 4.4. U.S. Connectivity Market Estimates & Forecast, by Connectivity
• 4.5. Connected
  • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.2. Bluetooth-Connected CPAP
    • 4.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.3. Wi-Fi & Cellular Connected CPAP
    • 4.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
  • 4.5.4. Hybrid-Connected
    • 4.5.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 4.6. Non-Connected
  • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis

• 5.1. U.S. CPAP Devices Market: End Use Movement Analysis
• 5.2. U.S. CPAP Devices Market: End Use Segment Dashboard
• 5.3. End Use Movement & Market Share Analysis, 2024 & 2030
• 5.4. U.S. CPAP Devices Market Estimates & Forecast, by End Use
• 5.5. Home Care Settings
  • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 5.6. Hospitals & Clinics
  • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)
• 5.7. Others (Long-Term Care Facilities, etc.)
  • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million) (000' Units)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategies of Market Players for Entry and Exit and its Impact on Market Competitors
• 6.3. Company Market Position Analysis
• 6.4. Company Share Analysis, from 2012 to 2024 (%)
• 6.5. Company Profiles/Listing
  • 6.5.1. ResMed
    • 6.5.1.1. Overview
    • 6.5.1.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.1.3. Product benchmarking
    • 6.5.1.4. Strategic initiatives
  • 6.5.2. Koninklijke Philips N.V.
    • 6.5.2.1. Overview
    • 6.5.2.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.2.3. Product benchmarking
    • 6.5.2.4. Strategic initiatives
  • 6.5.3. Fisher & Paykel Healthcare Limited
    • 6.5.3.1. Overview
    • 6.5.3.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.3.3. Product benchmarking
    • 6.5.3.4. Strategic initiatives
  • 6.5.4. React Health (3B Medical)
    • 6.5.4.1. Overview
    • 6.5.4.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.4.3. Product benchmarking
    • 6.5.4.4. Strategic initiatives
  • 6.5.5. Lowenstein Medical
    • 6.5.5.1. Overview
    • 6.5.5.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.5.3. Product benchmarking
    • 6.5.5.4. Strategic initiatives
  • 6.5.6. BMC Medical
    • 6.5.6.1. Overview
    • 6.5.6.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.6.3. Product benchmarking
    • 6.5.6.4. Strategic initiatives
  • 6.5.7. Wellell (Apex Medical)
    • 6.5.7.1. Overview
    • 6.5.7.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.7.3. Product benchmarking
    • 6.5.7.4. Strategic initiatives
  • 6.5.8. Armstrong Medical
    • 6.5.8.1. Overview
    • 6.5.8.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.8.3. Product benchmarking
    • 6.5.8.4. Strategic initiatives
  • 6.5.9. Breas Medical
    • 6.5.9.1. Overview
    • 6.5.9.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.9.3. Product benchmarking
    • 6.5.9.4. Strategic initiatives
  • 6.5.10. SEFAM
    • 6.5.10.1. Overview
    • 6.5.10.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.10.3. Product benchmarking
    • 6.5.10.4. Strategic initiatives
  • 6.5.11. Smiths Group PLC
    • 6.5.11.1. Overview
    • 6.5.11.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.11.3. Product benchmarking
    • 6.5.11.4. Strategic initiatives
  • 6.5.12. Transcend Inc. (Somnetics International, Inc.)
    • 6.5.12.1. Overview
    • 6.5.12.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.12.3. Product benchmarking
    • 6.5.12.4. Strategic initiatives
  • 6.5.13. Trudell Medical (Vyaire)
    • 6.5.13.1. Overview
    • 6.5.13.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.13.3. Product benchmarking
    • 6.5.13.4. Strategic initiatives
  • 6.5.14. Medical Depot, Inc. dba Drive DeVilbiss Healthcare.
    • 6.5.14.1. Overview
    • 6.5.14.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.14.3. Product benchmarking
    • 6.5.14.4. Strategic initiatives
  • 6.5.15. Invacare Corporation
    • 6.5.15.1. Overview
    • 6.5.15.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.15.3. Product benchmarking
    • 6.5.15.4. Strategic initiatives
  • 6.5.16. Others
    • 6.5.16.1. Overview
    • 6.5.16.2. Company performance (Unit Volume, ASP Trend & Market Value from 2012 to 2024)
    • 6.5.16.3. Product benchmarking
    • 6.5.16.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S continuous positive airway pressure devices market revenue estimates and forecast, by connectivity, 2018 - 2030 (USD Million) (000' Units)
• Table 4 U.S continuous positive airway pressure devices market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million) (000' Units)

List of Figures

• Fig. 1 U.S CPAP Devices Market Segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain based sizing & forecasting
• Fig. 7 QFD modelling for Market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Technology segment outlook
• Fig. 11 Application segment outlook
• Fig. 12 End Use segment outlook
• Fig. 13 Competitive landscape
• Fig. 14 U.S CPAP Devices Market: Market dynamics
• Fig. 15 U.S CPAP Devices Market: Porter's analysis
• Fig. 16 U.S CPAP Devices Market: PESTLE analysis
• Fig. 17 U.S CPAP Devices Market: Connectivity segment dashboard
• Fig. 18 U.S CPAP Devices Market: Connectivity movement share analysis
• Fig. 19 Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 20 Bluetooth-Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 21 Wi-Fi & Cellular Connected CPAP Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 22 Hybrid-Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 23 Non-Connected Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 24 U.S CPAP Devices Market: End Use Segment Dashboard
• Fig. 25 U.S CPAP Market: End Use Movement Share Analysis
• Fig. 26 Home Care Settings Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 27 Hospitals & Clinics Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 28 Others (Long-Term Care Facilities, etc.) Market, 2018 - 2030 (USD Million) (000' Units)
• Fig. 29 Company categorization
• Fig. 30 Company Market Share Analysis (2012 - 2024) Metrics Covered: Unit Volume, Average Selling Price (ASP), Market Value
• Fig. 31 Strategic framework